| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.28 | 0.03 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |